GO:0140228 histone benzoyllysine debenzoylase activity

Histone proteins undergo a wide array of post-translational modifications (PTMs) that regulate chromatin structure and gene expression. Among these, lysine acylation has emerged as a critical layer of epigenetic control. GO:0140228, histone benzoyllysine debenzoylase activity, represents a newly defined enzymatic activity that removes benzoyl groups from N6-benzoyllysine residues on histones. This reaction is NAD+-dependent and produces 2''-O-benzoyl-ADP-ribose, nicotinamide, and unmodified lysine. The discovery of this activity highlights the expanding complexity of histone acylation and its potential roles in cellular physiology and disease. Researchers are increasingly interested in histone benzoylation because it introduces a bulky, hydrophobic modification that can alter chromatin compaction and protein-protein interactions. The enzyme(s) responsible for removing this mark are just beginning to be characterized, and their identification has been facilitated by genetic code expansion techniques that allow site-specific incorporation of benzoyllysine into histones. Understanding GO:0140228 is therefore essential for deciphering how cells reverse benzoylation and maintain epigenetic homeostasis. This article provides a comprehensive overview of the molecular mechanism, key genes, regulatory features, and experimental models relevant to histone benzoyllysine debenzoylase activity. It is intended for researchers seeking to study this emerging PTM and its impact on gene regulation, development, and disease.

GO:0140228, histone benzoyllysine debenzoylase activity, is defined as the catalysis of the reaction: N(6)-benzoyl-L-lysyl-[protein] + NAD+ + H2O = 2''-O-benzoyl-ADP-D-ribose + nicotinamide + L-lysyl-[protein]. In simpler terms, it is an enzyme that removes a benzoyl group from a modified lysine on a histone protein, using NAD+ as a cofactor and water as a reactant, thereby regenerating an unmodified lysine.

Histone benzoylation is a recently discovered PTM that adds a bulky benzoyl group to lysine residues, potentially altering chromatin structure and gene expression. The enzyme activity that removes this mark, GO:0140228, is crucial for reversing benzoylation and maintaining dynamic regulation of histone modifications. Dysregulation of this activity could lead to aberrant gene expression and has been implicated in cancer and metabolic diseases, although direct evidence is still emerging. Studying this activity provides insights into the broader family of NAD+-dependent deacylases and their roles in epigenetic regulation.

The following genes and proteins are implicated in histone benzoylation and de-benzoylation pathways, based on current literature.

The activity of histone benzoyllysine debenzoylase is likely regulated by cellular NAD+ levels, as NAD+ is a required cofactor. Additionally, post-translational modifications of the enzyme itself, such as phosphorylation or acetylation, may modulate its activity. The expression levels of candidate debenzoylases could also be controlled transcriptionally in response to metabolic or stress signals. However, specific regulatory mechanisms remain largely unexplored and represent an important area for future research.

Altered histone benzoylation and de-benzoylation may contribute to cancer by affecting the expression of oncogenes and tumor suppressors. For example, dysregulation of NAD+-dependent deacylases like sirtuins has been linked to tumorigenesis, and benzoyllysine removal could be part of this process.

Because the debenzoylase reaction consumes NAD+, changes in cellular metabolism that affect NAD+ availability could impact histone benzoylation dynamics. This links the activity to metabolic disorders such as diabetes and obesity, where NAD+ levels are often perturbed.

NAD+ depletion is a hallmark of several neurodegenerative diseases, and impaired debenzoylase activity could contribute to epigenetic dysregulation in neurons. However, direct evidence for a role of histone benzoyllysine debenzoylase in neurodegeneration is currently lacking.

This technique allows site-specific incorporation of N6-benzoyllysine into histones in living cells, enabling precise studies of benzoylation and de-benzoylation. It is particularly useful for generating substrates for debenzoylase assays.

Recombinant enzymes can be incubated with benzoyllysine-containing peptides or proteins, and the reaction products analyzed by mass spectrometry or HPLC to measure debenzoylase activity.

Global analysis of histone modifications by mass spectrometry can identify changes in benzoylation levels upon knockdown or overexpression of candidate debenzoylases.

Genome-wide CRISPR knockout or activation screens can be used to identify genes that regulate histone benzoylation or that are required for cell growth when debenzoylases are lost.

Researchers studying histone benzoyllysine debenzoylase activity-related genes often need to determine whether a candidate gene is causally involved in this epigenetic modification. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.

Histone benzoyllysine debenzoylase activity (GO:0140228) represents a newly defined enzymatic function that removes benzoyl groups from histones in an NAD+-dependent manner. This activity is part of the expanding landscape of histone acylation and deacylation, with potential implications for chromatin regulation and disease. Continued research using advanced tools such as genetic code expansion and CRISPR-based models will be essential to identify the specific enzymes, understand their regulation, and explore their therapeutic potential.